Cite
Jing Z, Gao J, Li J, et al. Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy. Cancer Lett. 2021;519:46-62doi: 10.1016/j.canlet.2021.06.016.
Jing, Z., Gao, J., Li, J., Niu, F., Tian, L., Nan, P., Sun, Y., Xie, X., Zhu, Y., Zhao, Y., Liu, F., Zhou, L., Sun, Y., & Zhao, X. (2021). Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy. Cancer letters, 51946-62. https://doi.org/10.1016/j.canlet.2021.06.016
Jing, Zongpan, et al. "Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy." Cancer letters vol. 519 (2021): 46-62. doi: https://doi.org/10.1016/j.canlet.2021.06.016
Jing Z, Gao J, Li J, Niu F, Tian L, Nan P, Sun Y, Xie X, Zhu Y, Zhao Y, Liu F, Zhou L, Sun Y, Zhao X. Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy. Cancer Lett. 2021 Oct 28;519:46-62. doi: 10.1016/j.canlet.2021.06.016. Epub 2021 Jun 21. PMID: 34166767.
Copy
Download .nbib